The roles of FADD in extrinsic apoptosis and necroptosis
2
조회
0
다운로드
7
인용
0
참고문헌
키워드
초록
Fas-associated protein with death domain (FADD), an adaptor that bridges death receptor signaling to the caspase cascade, is indispensible for the induction of extrinsic apoptotic cell death. Interest in the non-apoptotic function of FADD has greatly increased due to evidence that FADD-deficient mice or dominant-negative FADD transgenic mice result in embryonic lethality and an immune defect without showing apoptotic features. Numerous studies have suggested that FADD regulates cell cycle progression, proliferation, and autophagy, affecting these phenomena. Recently, programmed necrosis, also called necroptosis, was shown to be a key mechanism that induces embryonic lethality and an immune defect. Supporting these findings, FADD was shown to be involved in various necroptosis models. In this review, we summarize the mechanism of extrinsic apoptosis and necroptosis, and discuss the in vivo and in vitro roles of FADD in necroptosis induced by various stimuli. [BMB Reports 2012; 45(9): 496-508]
Abstract
Fas-associated protein with death domain (FADD), an adaptor that bridges death receptor signaling to the caspase cascade, is indispensible for the induction of extrinsic apoptotic cell death. Interest in the non-apoptotic function of FADD has greatly increased due to evidence that FADD-deficient mice or dominant-negative FADD transgenic mice result in embryonic lethality and an immune defect without showing apoptotic features. Numerous studies have suggested that FADD regulates cell cycle progression, proliferation, and autophagy, affecting these phenomena. Recently, programmed necrosis, also called necroptosis, was shown to be a key mechanism that induces embryonic lethality and an immune defect. Supporting these findings, FADD was shown to be involved in various necroptosis models. In this review, we summarize the mechanism of extrinsic apoptosis and necroptosis, and discuss the in vivo and in vitro roles of FADD in necroptosis induced by various stimuli. [BMB Reports 2012; 45(9): 496-508]
참고문헌 (138)
- Werner, M. H., "Emerging roles for the death adaptor FADD in death re-ceptor avidity and cell cycle regulation", Cell Cycle., 5, pp.2332~2338 (2006)
- Tourneur, L., "FADD: a regulator of life and death", Trends Immunol., 31, pp.260~269 (2010)
- Alappat, E. C., "Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities", Mol. Cell, 19, pp.321~332 (2005)
- 장문선, "Phosphorylation by polo-like kinase 1 induces the tumor-suppressing activity of FADD", ONCOGENE, 30(4), pp.471~481, NATURE PUBLISHING GROUP
- Jang, M. S., "Cooperative Phosphorylation of FADD by Aur-A and Plk1 in Response to Taxol Triggers Both Apoptotic and Necrotic Cell Death", CANCER RESEARCH, 71(23), pp.7207~7215 (2011), AMER ASSOC CANCER RESEARCH
- Alappat, E. C., "Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site", J. Biol. Chem., 278, pp.41585~41588 (2003)
- Rochat-Steiner, V., "FIST", HIPK3: a Fas, threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation, pp.J. Exp. Med., 2000[DOI]
- Scaffidi, C., "Phosphorylation of FADD", MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase, 2000, pp.164, 1236~1242
- Schrijvers, M. L., "FADD expression as a prognosticator in early-stage glottic squamous cell carcinoma of the larynx treated primarily with radiotherapy", Int. J. Radiat. Oncol. Biol. Phys., 83, pp.1220~1226 (2012)
- Schinske, K. A., "A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NFkappaB", Mol. Cancer Ther., 10, pp.1807~1817 (2011)
- Bhojani, M. S., "Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer", Cell Cycle., 4, pp.1478~1481 (2005)
- Chen, G., "Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas", Proc. Natl. Acad. Sci. U.S.A., 102, pp.12507~12512 (2005)
- Tourneur, L., "Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells", Oncogene, 22, pp.2795~2804 (2003)
- Tourneur, L., "Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome", Cancer Res., 64, pp.8101~8108 (2004)
- Bonnet, M. C., "The adaptor protein fadd protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation", Immunity, 35, pp.572~582 (2011)
- Lu, J. V., "Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity", Proc. Natl. Acad. Sci. U.S.A., 108, pp.15312~15317 (2011)
- Welz, P. S., "FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation", Nature, 477, pp.330~334 (2011)
- Zhang, H., "Functional complementation between FADD and RIP1 in embryos and lymphocytes", Nature, 471, pp.373~376 (2011)
- Holler, N., "Fas triggers an alternative, caspase- 8-independent cell death pathway using the kinase RIP as effector molecule", Nat. Immunol., 1, pp.489~495 (2000)
- Lin, Y., "Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis", Genes Dev., 13, pp.2514~2526 (1999)
- Feng, S., "Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain", Cell Signal, 19, pp.2056~2067 (2007)
- O'Donnell, M. A., "Caspase 8 inhibits programmed necrosis by processing CYLD", Nat. Cell Biol., 13, pp.1437~1442 (2011)
- Kroemer, G., "Mitochondrial membrane permeabilization in cell death", Physiol. Rev., 87, pp.99~163 (2007)
- Mahmood, Z., "Death receptors: targets for cancer therapy", Exp. Cell Res., 316, pp.887~899 (2010)
- Mc Guire, C., "Death receptor signalling in central nervous system inflammation and demyelination", Trends Neurosci., 34, pp.619~628 (2011)
- French, L. E., "Protein-based therapeutic approaches targeting death receptors", Cell Death Differ., 10, pp.117~123 (2003)
- Wajant, H., "Death receptors", Essays Biochem., 39, pp.53~71 (2003)
- Kischkel, F. C., "Cytotoxicity- dependent APO-1 (Fas", CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor, 1995, pp.14, 5579~5588
- Scaffidi, C., "Two CD95 (APO-1", Fas) signaling pathways, 1998, pp.17, 1675~1687
- Barnhart, B. C., "The CD95 type I", type II model, 2003, pp.15, 185~193
- Yin, X. M., "Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis", Nature, 400, pp.886~891 (1999)
- Ozoren, N., "Defining characteristics of Types I and II apoptotic cells in response to TRAIL", Neoplasia, 4, pp.551~557 (2002)
- Willis, S. N., "Life in the balance: how BH3-only proteins induce apoptosis", Curr. Opin. Cell Biol., 17, pp.617~625 (2005)
- Johnstone, R. W., "The TRAIL apoptotic pathway in cancer onset, progression and therapy", Nat. Rev. Cancer, 8, pp.782~798 (2008)
- Verhagen, A. M., "Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins", Cell, 102, pp.43~53 (2000)
- Du, C., "Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition", Cell, 102, pp.33~42 (2000)
- Lavrik, I., "Death receptor signaling", J. Cell Sci., 118, pp.265~267 (2005)
- Wilson, N. S., "Death receptor signal transducers: nodes of coordination in immune signaling networks", Nat. Immunol., 10, pp.348~355 (2009)
- Symons, A., "MAP kinase kinase kinases and innate immunity", Trends Immunol., 27, pp.40~48 (2006)
- Varfolomeev, E. E., "Tumor necrosis factor: an apoptosis JuNKie?", Cell, 116, pp.491~497 (2004)
- Bertrand, M. J., "cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination", Mol. Cell, 30, pp.689~700 (2008)
- Ea, C. K., "Activation of IKK by TNFalpha requires site-specificubiquitination of RIP1 and polyubiquitin binding byNEMO", Mol. Cell, 22, pp.245~257 (2006)
- Kanayama, A., "TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains", Mol. Cell, 15, pp.535~548 (2004)
- Declercq, W., "RIP kinases at the crossroads of cell death andsurvival", Cell, 138, pp.229~232 (2009)
- Vandenabeele, P., "Molecular mechanisms of necroptosis: an ordered cellular explosion", Nat. Rev. Mol. Cell Biol., 11, pp.700~714 (2010)
- Shembade, N., "Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes", Science, 327, pp.1135~1139 (2010)
- Enesa, K., "NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling", J. Biol. Chem., 283, pp.7036~7045 (2008)
- Xu, G., "Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1", J. Biol. Chem., 285, pp.969~978 (2010)
- Wang, L., "TNF-alpha induces two distinct caspase-8 activation pathways", Cell, 133, pp.693~703 (2008)
- Schutze, S., "Regulation of TNFR1 and CD95 signalling by receptorcompartmentalization", Nat. Rev. Mol. Cell Biol., 9, pp.655~662 (2008)
- Varfolomeev, E., "Un)expected roles of c-IAPs in apoptotic and NFkappaB signaling pathways", Cell Cycle, 7, pp.1511~1521 (2008)
- Vince, J. E., "IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis", Cell, 131, pp.682~693 (2007)
- Ozturk, S., "Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions", Exp. Cell Res., 318, pp.1324~1331 (2012)
- Yu, J. W., "FLIP and the death effector domain family", Oncogene, 27, pp.6216~6227 (2008)
- Micheau, O., "The long form of FLIP is an activator of caspase- 8 at the Fas death-inducing signaling complex", J. Biol. Chem., 277, pp.45162~45171 (2002)
- Boatright, K. M., "Activation of caspases-8 and -10 by FLIP(L)", Biochem. J., 382, pp.651~657 (2004)
- Chang, L., "The E3 ubiquitin ligase itch couples JNK activation to TNFalphainduced cell death by inducing c-FLIP(L) turnover", Cell, 124, pp.601~613 (2006)
- Panka, D. J., "Phosphatidylinositol 3-kinase", Akt activity reg-ulates c-FLIP expression in tumor cells, 2001, pp.276, 6893~6896
- Pennarun, B., "Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer", Biochim. Biophys. Acta., 1805, pp.123~140 (2010)
- Feig, C., "Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling", EMBO J., 26, pp.221~231 (2007)
- Wagner, K. W., "Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L", TRAIL, 2007, pp.13, 1070~1077
- Kaunisto, A., "PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability", Cell Death Differ., 16, pp.1215~1226 (2009)
- Chanvorachote, P., "Nitric oxide negatively regulates Fas CD95-induced apoptosis through inhibition of ubiquitin-proteasome-mediated degradation of FLICE inhibitory protein", J. Biol. Chem., 280, pp.42044~42050 (2005)
- Poukkula, M., "Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail", J. Biol. Chem., 280, pp.27345~27355 (2005)
- Kim, Y., "An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis", J. Biol. Chem., 277, pp.22320~22329 (2002)
- Perez, D., "E1A sensitizes cells to tumor necrosis factor alpha by downregulating c-FLIP S", J Virol., 77, pp.2651~2662 (2003)
- Cursi, S., "Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression", EMBO J., 25, pp.1895~1905 (2006)
- McDonald, E. R., 3rd, "Suppression of caspase-8- and -10-associated RING proteins results in sensitization to death ligands and inhibition of tumor cell growth", Proc. Natl. Acad. Sci. U.S.A., 101, pp.6170~6175 (2004)
- Liao, W., "CARP-2 is an endosome- associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation", Curr. Biol., 18, pp.641~649 (2008)
- Jesenberger, V., "Deadly encounter: ubiquitin meets apoptosis", Nat. Rev. Mol. Cell Biol., 3, pp.112~121 (2002)
- Lee, J. C., "Regulation of apoptosis by ubiquitination", Immunol. Rev., 193, pp.39~47 (2003)
- Lee, E. W., "Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis", NATURE COMMUNICATIONS, 3, pp.978~ (2012), NATURE PUBLISHING GROUP
- Laster, S. M., "Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis", J. Immunol., 141, pp.2629~2634 (1988)
- 허강민, "Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation", JOURNAL OF BIOLOGICAL CHEMISTRY, 279(11), pp.10822~10828, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
- Vercammen, D., "Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways", J. Exp. Med., 188, pp.919~930 (1998)
- Degterev, A., "Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury", Nat. Chem. Biol., 1, pp.112~119 (2005)
- Chan, F. K., "A role for tumor necrosis factor receptor-2 and receptor- interacting protein in programmed necrosis and antiviral responses", J. Biol. Chem., 278, pp.51613~51621 (2003)
- He, S., "Receptor interacting protein kinase- 3 determines cellular necrotic response to TNFalpha", Cell, 137, pp.1100~1111 (2009)
- Cho, Y. S., "Phosphorylationdriven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation", Cell, 137, pp.1112~1123 (2009)
- Zhang, D. W., "RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis", Science, 325, pp.332~336 (2009)
- Ma, Y., "NFkappaB protects macrophages from lipopolysaccharideinduced cell death: the role of caspase 8 and receptor-interacting protein", J. Biol. Chem., 280, pp.41827~41834 (2005)
- Upton, J. W., "Virus inhibition of RIP3-dependent necrosis", Cell Host & Microbe, 7, pp.302~313 (2010)
- Kalai, M., "Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsRNA", Cell Death Differ., 9, pp.981~994 (2002)
- Apetoh, L., "Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy", Nat. Med., 13, pp.1050~1059 (2007)
- Hacker, H., "Regulation and function of IKK and IKK-related kinases", Sci. STKE, 2006, pp.re13~ (2006)
- Hitomi, J., "Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway", Cell, 135, pp.1311~1323 (2008)
- Laukens, B., "Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor alpha-induced necroptosis", Neoplasia, 13, pp.971~979 (2011)
- McComb, S., "cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation", Cell Death Differ. (2012)
- Moulin, M., "IAPs limit activation of RIP kinases by TNF receptor 1 during development", EMBO J., 31, pp.1679~1691 (2012)
- Vanlangenakker, N., "TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members", Cell Death Dis., 2, pp.e230~ (2011)
- Micheau, O., "Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes", Cell, 114, pp.181~190 (2003)
- Degterev, A., "Identification of RIP1 kinase as a specific cellular target of necrostatins", Nat. Chem. Biol., 4, pp.313~321 (2008)
- Duprez, L., "RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome", Immunity, 35, pp.908~918 (2011)
- Vercammen, D., "Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor", J. Exp. Med., 187, pp.1477~1485 (1998)
- Bohgaki, T., "Caspase-8 inactivation in T cells increases necroptosis and suppresses autoimmunity in Bim-", - mice, 2011, pp.195, 277~291
- Gunther, C., "Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis", Nature, 477, pp.335~339 (2011)
- Schulze-Osthoff, K., "Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation", J. Biol. Chem., 267, pp.5317~5323 (1992)
- Antosiewicz, J., "Tumor necrosis factor-alpha- induced reactive oxygen species formation is mediated by JNK1-dependent ferritin degradation and elevation of labile iron pool", Free Radic. Biol. Med., 43, pp.265~270 (2007)
- Xie, C., "Distinct roles of basal steady-state and induced H-ferritin in tumor necrosis factor- induced death in L929 cells", Mol. Cell Biol., 25, pp.6673~6681 (2005)
- Murthy, C. R., "Ammonia-induced production of free radicals in primary cultures of rat astrocytes", J. Neurosci. Res., 66, pp.282~288 (2001)
- Van Herreweghe, F., "Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE", Proc. Natl. Acad. Sci. U.S.A., 99, pp.949~954 (2002)
- Albrecht, J., "Glutamine: a Trojan horse in ammonia neurotoxicity", Hepatology, 44, pp.788~794 (2006)
- Soldani, C., "Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update", Apoptosis, 7, pp.321~328 (2002)
- Saelens, X., "Protein synthesis persists during necrotic cell death", J. Cell Biol., 168, pp.545~551 (2005)
- Sun, X. M., "Caspase activation inhibits proteasome function during apoptosis", Mol. Cell, 14, pp.81~93 (2004)
- Los, M., "Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling", Mol. Biol. Cell, 13, pp.978~988 (2002)
- Benedetti, A., "Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids", Biochim. Biophys. Acta., 620, pp.281~296 (1980)
- Orrenius, S., "Mitochondrial oxidative stress: implications for cell death", Annu. Rev. Pharmacol. Toxicol., 47, pp.143~183 (2007)
- Won, J. S., "Sphingolipid signaling and redox regulation", Free Radic. Biol. Med., 40, pp.1875~1888 (2006)
- Kagedal, K., "Sphingosine-induced apoptosis is dependent on lysosomal proteases", Biochem. J., 359, pp.335~343 (2001)
- Sun, L., "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase", Cell, 148, pp.213~227 (2012)
- Wang, Z., "The mitochondrial phosphatase PGAM5 functionsat the convergence point of multiple necrotic deathpathways", Cell, 148, pp.228~243 (2012)
- Yeh, W. C., "FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis", Science, 279, pp.1954~1958 (1998)
- Zhang, J., "Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD", Mort1, 1998, pp.392, 296~300
- Bodmer, J. L., "TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat", Cell Biol., 2, pp.241~243 (2000)
- Kischkel, F. C., "Apo2L", TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5, 2000, pp.12, 611~620
- Sprick, M. R., "FADD", MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2, 2000, pp.12, 599~609
- Irrinki, K. M., "Requirement of FADD, NEMO, and BAX", BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis, 2011, pp.31, 3745~3758
- Oberst, A., "Catalytic activity of the caspase- 8-FLIP(L) complex inhibits RIPK3-dependent necrosis", Nature, 471, pp.363~367 (2011)
- Jin, Z., "Distinct signaling pathways in TRAIL- versus tumor necrosis factor-induced apoptosis", Mol. Cell Biol., 26, pp.8136~8148 (2006)
- Vercammen, D., "Tumour necrosis factor-induced necrosis versus anti-Fas-induced apoptosis in L929 cells", Cytokine, 9, pp.801~808 (1997)
- Vanlangenakker, N., "Many stimuli pull the necrotic trigger, an overview", Cell Death Differ., 19, pp.75~86 (2012)
- He, S., "Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway", Proc. Natl. Acad. Sci. U.S.A., 108, pp.20054~20059 (2011)
- Meylan, E., "RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation", Nat. Immunol., 5, pp.503~507 (2004)
- Upton, J. W., "DAI", ZBP1, Cell Host & Microbe, pp.2012, 11[DOI]
- Rebsamen, M., "DAI", ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB, 2009, pp.10, 916~922
- Feoktistova, M., "cIAPs block Ripoptosome formation, a RIP1", caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms, 2011, pp.43, 449~463
- Tenev, T., "The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs", Mol. Cell, 43, pp.432~448 (2011)
- Shen, H. M., "Essential roles of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death", Mol. Cell Biol., 24, pp.5914~5922 (2004)
- Newton, K., "A dominant interfering mutant of FADD", MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes, 1998, pp.17, 706~718
- Walsh, C. M., "A role for FADD in T cell activation and development", Immunity, 8, pp.439~449 (1998)
- Kabra, N. H., "T cell-specific FADD-deficient mice: FADD is required for early T cell development", Proc. Natl. Acad. Sci. U.S.A., 98, pp.6307~6312 (2001)
- Osborn, S. L., "Constitutive phosphorylation mutation in Fas-associated death domain (FADD) results in early cell cycle defects", J. Biol. Chem., 282, pp.22786~22792 (2007)
- Imtiyaz, H. Z., "The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation", J. Biol. Chem., 284, pp.9917~9926 (2009)
- Osborn, S. L., "Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis", Proc. Natl. Acad. Sci. U.S.A., 107, pp.13034~13039 (2010)
- Bell, B. D., "FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells", Proc. Natl. Acad. Sci. U.S.A., 105, pp.16677~16682 (2008)
- Kaiser, W. J., "RIP3 mediates the embryonic lethality of caspase-8-deficient mice", Nature, 471, pp.368~372 (2011)
- Ch'en, I. L., "Mechanisms of necroptosis in T cells", J. Exp. Med., 208, pp.633~641 (2011)
